Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Secondary endpoints included the proportion of patients who achieved 10-15% reduction in weight and changes in metabolic syndrome parameters (waist circumference, HbA 1c , and blood pressure)
Its action on GLP-1 and GIP receptors enhances insulin secretion and regulates glucose metabolism, which may help stabilize blood sugar levels
Aims The aim of this study was to describe experiences of self-administering GLP-1 receptor agonists and its perceived impact on mental health in patients with obesity and/or T2D
Trop-Steinberg S et al
Were gonna see what those say
Results Thirty-one interviews were conducted with pALS: seven (23%) had SOD1-ALS, the mean age was 42.4 years (SD=11.5), 81% were female, 84% were White, and 61% were living with their spouse/significant other (Table)
:max_bytes(150000):strip_icc()/WhatstheDifferenceBetweenOzempicWegovyandMounjaro-illo-a8f5a23fe4914586b4488472fe15f112.png)
